EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Selectivity of Butyrylcholinesterase Inhibitors Revisited

Michael D Gambardella, Yigui Wang, Jiongdong Pang

Molecules · 27.10.2025 · 30 (21) · 4201

DOI: 10.3390/molecules30214201 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 27.10.2025. Verfasst von Michael D Gambardella und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Pittsburgh, Pittsburgh, PA 15260, USA. Hauptthemen laut MEDLINE: Butyrylcholinesterase, Cholinesterase Inhibitors, Alzheimer Disease. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Southern Connecticut State University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acetylcholinesterase (AChE) inhibitors are the primary target for single-molecule anti-Alzheimer’s disease (AD) therapeutics. Though AChE has historically been the focus of investigation for small-molecule inhibitors, interest in another cholinergic enzyme, butyrylcholinesterase (BChE), has grown in recent years. Attention stems from BChE’s role in β-amyloid (Aβ) protein aggregation and an increase in BChE concentration during the late stages of AD, where a decrease in AChE concentration is also observed. Currently, five FDA-approved drugs are on the market for inhibiting AChE, though no BChE-selective drugs have been approved so far. In this review, we focus on newly identified BChE selective inhibitors and present the ideas behind these discoveries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ButyrylcholinesteraseCholinesterase InhibitorsAlzheimer DiseaseHumansAcetylcholinesteraseAnimalsAmyloid beta-Peptides

Stichwörter der Autor:innen

Alzheimer’s diseaseBChE selectivityacetylcholinesterasebutyrylcholinesteraseinhibitorsynthesisvirtual screening

Substanzen

ButyrylcholinesteraseCholinesterase InhibitorsAcetylcholinesteraseAmyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Chemistry, University of Pittsburgh, Pittsburgh, PA 15260, USA.
  • Department of Chemistry and Biochemistry, Southern Connecticut State University, New Haven, CT 06515, USA.
  • Department of Chemistry and Chemical & Biochemical Engineering, University of New Haven, West Haven, CT 06516, USA.

Förderung

  • Southern Connecticut State University

Zitieren

APA

Gambardella, M. D., Wang, Y., & Pang, J. (2025). The Selectivity of Butyrylcholinesterase Inhibitors Revisited. Molecules, 30(21), 4201. https://doi.org/10.3390/molecules30214201

Vancouver

Gambardella MD, Wang Y, Pang J. The Selectivity of Butyrylcholinesterase Inhibitors Revisited. Molecules. 2025;30(21):4201. doi:10.3390/molecules30214201

BibTeX
@article{Gambardella2025,
  author = {Gambardella, Michael D and Wang, Yigui and Pang, Jiongdong},
  title = {The Selectivity of Butyrylcholinesterase Inhibitors Revisited},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {21},
  pages = {4201},
  doi = {10.3390/molecules30214201}
}
Kostenlos starten →